<code id='6809DB5667'></code><style id='6809DB5667'></style>
    • <acronym id='6809DB5667'></acronym>
      <center id='6809DB5667'><center id='6809DB5667'><tfoot id='6809DB5667'></tfoot></center><abbr id='6809DB5667'><dir id='6809DB5667'><tfoot id='6809DB5667'></tfoot><noframes id='6809DB5667'>

    • <optgroup id='6809DB5667'><strike id='6809DB5667'><sup id='6809DB5667'></sup></strike><code id='6809DB5667'></code></optgroup>
        1. <b id='6809DB5667'><label id='6809DB5667'><select id='6809DB5667'><dt id='6809DB5667'><span id='6809DB5667'></span></dt></select></label></b><u id='6809DB5667'></u>
          <i id='6809DB5667'><strike id='6809DB5667'><tt id='6809DB5667'><pre id='6809DB5667'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:6
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Scientists uncover potential path to treating deadly childhood tumor
          Scientists uncover potential path to treating deadly childhood tumor

          Stainofabiopsyspecimenofarhabdoidtumor.WikimediaCommonsMosttargetedcancerdrugsworkliketranquilizerda

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          U.K. sequencing study surfaces new findings about tumor DNA

          AdobeLONDON—Adecadeago,theU.K.launchedits100,000GenomesProject,amajorresearchendeavorthatinvolvedseq